|
Phase: 1 |
| Protocol No. |
Title |
| 1999LS073 |
MT1999-20 Hematopoietic cell transplantation in children with juvenile myelomonocytic leukemia |
| 2004LS034 |
MT2004-03: A Dose Escalation Study of CD4+ CD25+ Cells in Adult Patients Undergoing HLA-Identical Sibling Donor Peripheral Blood Progenitor Cell (PBPC) Transplantation" MT2004-03: A Clinical Trial of Adult CD4+ CD25+ Regulatory T Cells in BMT Recipients |
| 2004LS042 |
MT2003-23: Reduced Intensity Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) Supplemented with Donor Natural Killer (NK) Cell Infusions in Patients with High Risk Myeloid Malignancies who are Unsuitable for Fully Myeloablative Transplantation with a Phase II, Open Label Study of Bortezomib in the Preparative Regimen |
| 2005CG018 |
COG ADVL04P2: A Feasibility Pilot and Phase II Study of Chemoimmunotherapy with Epratuzumab (IND#12034) for Children with Relapsed CD22-positive Acute Lymphoblastic Leukemia (ALL) |
| 2005LS023 |
MT2004-30: Dose Escalation of Total Marrow Irradiation Added To An Alkylator-Intense Conditioning Regimen For Patients with High Risk or Relapsed Solid Tumors |
| 2005LS068 |
Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies |
| 2006CG033 |
COG ADVL0413: A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772, IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias |
| 2006IS047 |
A Phase 1 Pharmacodynamic Study of CP-751,871 as Neoadjuvant Treatment for Early Breast Cancer |
| 2006LS057 |
MT2006-09: Phase I Open Label, Single Arm Escalation Trial to Evaluate the Biodistribution and Safety of BU-12 in Patients with Advanced Leukemia |
| 2006UC048 |
Phase I and II Study of Stereotactic Body Radiation Therapy (SBRT) for Low and Intermediate Risk Prostate Cancer |
| 2007CG010 |
COG ADVL0612: A Phase I Study of Sunitinib, an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors |
| 2007IS117 |
Amgen 20050252: A Phase I Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors |
| 2007LS019 |
Phase I Clinical Trial of Trametes Versicolor in Women with Breast Cancer |
| 2007LS022 |
MT2006-01: Phase I Study of Infusion of Umbilical Cord Blood (UCB) Derived CD25+ CD4+ T-Regulatory (Treg) Cells After Non-Myeloablative Cord Blood Transplantation |
| 2007LS064 |
MT2007-12: Allogeneic Natural Killer Cells with Rituximab in Patients with CD20 Positive Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia ALSO -- Strategies to Increase Sensitivity of CLL Tumor Cells to Natural Killer Cell-Immune-Mediated Cytolysis |
| 2007NT121 |
A Phase I Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin (FK463) in Children (2-5yrs and 6-11 yrs) and Adolescents (12-16 yrs.) with Esophageal Candidiasis or other Invasive Candidiasis (Astellas 9463-CL-2101) |
| 2008CG069 |
COG ADVL0714 "A Phase I Study of VEGF Trap (NSC# 724770, IND #100137) in Children with Refractory Solid Tumors" |
| 2008CG076 |
CALGB 30504: Combination Chemotherapy With or Without Maintainence Sunitinib Malate (IND 74019; NSC 736511) for Untreated Extensive Stage Small Cell Lung Cancer: A phase IB/Randomized Phase II study |
| 2008CG164 |
COG ADVL0812 A Phase I Study of MLN8237, an Oral Selective Small Molecule Inhibitor of Aurora A Kinase, in Children with Relapsed/Refractory Solid Tumors and Leukemia |
| 2008IS063 |
A Phase 1b Study of LY573636-Sodium in Combination with Sunitinib Malate in Patients with Metastatic Renal Cancer |
| 2008LS035 |
Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life |
| 2008LS047 |
WCC #50 - Phase I Trial of Lenalidomide in Combination with Liposomal Doxorubicin for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer |
| 2008LS139 |
MT2008-38: A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies |
| 2008NTLS103 |
Iron Overload in Allgeneic Hematopoietic Cell Transplantation |
| 2009CG038 |
COG ADVL0813, A Phase I Study of IMC-A12 (Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody) in Combination with CCI-779 (Temsirolimus) in Pediatric Patients with Recurrent or Refractory Solid Tumors |
| 2009CG113 |
ADVL0912: A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma |
| 2009UC052 |
T2005-003: A Study of Bortezomib With Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia |
| MT2007-10 |
Intrathecal Enzyme Replacement Therapy for Patients with Mucopolysaccharidosis Type I (Hurler Syndrome) |
Clinical Trials Help